The global biosimilar market is expected to grow at a compound annual growth rate (CAGR) of 18.32% from 2024 to 2034. By the end of the forecast period, the market is projected to reach USD 125.32 billion, up from an estimated value of USD 27.46 billion in 2024. This robust growth is driven by the increasing demand for affordable alternatives to expensive biologic treatments, advancements in biotechnology, and the expansion of healthcare access worldwide.

Market Scope

Market Size in 2024: USD 27.46 Billion

Market Forecast in 2034: USD 125.32 Billion

CAGR (2024-2034): 18.32%

Base Year: 2023

Historic Data: 2016-2022

Forecast Period: 2024-2034

Report USP: Includes analysis of production, consumption, company share, company heatmap, production capacity, growth factors, and more.

Request Sample Copy: https://wemarketresearch.c...